Sign in
4

Changes in Ownership

IN8BIO, INC. Filed Acc 0001209191-23-039508

Options or other derivatives

  • Chief Operating Officer acquired 67,800 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Rochlin Kate Chief Operating Officer 2023-06-21 Grant or award · Employee Stock Option (right to buy) +67,800 67,800 D: show line 1 in the form
Loading xslF345X04/doc4.xml…